Stay updated on Safety of SEA-BCMA in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Safety of SEA-BCMA in Multiple Myeloma Clinical Trial page.

Latest updates to the Safety of SEA-BCMA in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check19 days agoChange DetectedA notice appears above the study record history announcing NIH website changes and saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check26 days agoChange DetectedThe website’s footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check33 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.7.0 was added to the study history, indicating an update to the record, while the previous revision v3.6.6 was removed from the history.SummaryDifference0.1%

- Check75 days agoChange DetectedThe revision label in the header updated from v3.6.5 to v3.6.6, signaling a new revision entry in the study's history.SummaryDifference0.1%

Stay in the know with updates to Safety of SEA-BCMA in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SEA-BCMA in Multiple Myeloma Clinical Trial page.